Crystal Structure of Fab Hgr-2 F6, a Competitive antagonist of the Glucagon Receptor
PDB | 1dqd |
Species | MUS MUSCULUS |
Method | X-RAY DIFFRACTION |
Resolution | 2.1Å |
Number of Fvs | 1 |
In complex | True |
Light chain type | Kappa |
Has constant region | True |
|
Display options: |
This PDB has 1 Fv(s).
Fv Details | |
---|---|
Heavy chain | H |
Light chain | L |
Heavy subgroup | IGHV3 |
Light subgroup | IGKV4 |
Species | MUS MUSCULUS |
In complex? | True |
scFv? | False |
Has constant domain? | True |
Numbered Sequences (chothia) |
---|
Heavy chain
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 52A | 53 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 82A | 82B | 82C | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 100A | 100B | 100C | 100D | 100E | 100F | 101 | 102 | 103 | 104 | 105 | 106 | 107 | 108 | 109 | 110 | 111 | 112 | 113 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E | V | Q | L | Q | E | S | G | P | S | L | V | K | P | S | Q | T | L | S | L | T | C | S | V | T | G | D | S | I | T | S | G | Y | W | N | W | I | R | K | F | P | G | N | K | L | E | Y | M | G | Y | I | S | Y | S | G | S | T | Y | Y | N | P | S | L | K | S | R | L | S | I | T | R | D | T | S | R | N | Q | Y | Y | L | Q | L | K | S | V | T | P | E | D | T | A | T | Y | Y | C | A | S | P | P | G | Y | Y | G | S | G | P | Y | A | M | D | Y | W | G | Q | G | T | S | V | T | V | S | S |
Light chain
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | I | V | L | S | Q | S | P | A | I | M | S | A | S | P | G | E | K | V | T | I | T | C | S | A | S | S | S | V | S | Y | M | H | W | F | Q | Q | K | P | G | T | S | P | K | L | C | I | Y | T | T | S | N | L | A | S | G | V | P | A | R | F | S | G | S | G | S | G | T | S | Y | S | L | T | I | S | R | M | E | A | E | D | A | A | T | Y | Y | C | Q | Q | R | S | T | Y | P | P | T | F | G | S | G | T | K | L | E | I | K |
Antigen Details | |
---|---|
Antigen chains | |
Antigen type | |
Antigen name | |
Antigen species | SYNTHETIC CONSTRUCT |
Antigen sequence |
CDR Sequences (chothia definition) | |
---|---|
CDRH1 | GDSITSG |
CDRH2 | SYSGS |
CDRH3 | PPGYYGSGPYAMDY |
CDRL1 | SASSSVSYMH |
CDRL2 | TTSNLAS |
CDRL3 | QQRSTYPPT |
Orientation Angles (from ABangle) | |
---|---|
HL | -60.01° |
HC1 | 73.22° |
HC2 | 119.07° |
LC1 | 120.31° |
LC2 | 80.55° |
dc | 16.3Å |
Schneider, C., Raybould, M.I.J., Deane, C.M. (2022) SAbDab in the Age of Biotherapeutics: Updates including SAbDab-Nano, the Nanobody Structure Tracker. Nucleic Acids Res. 50(D1):D1368-D1372 [link]
SAbDab paper: Dunbar, J., Krawczyk, K. et al (2014). Nucleic Acids Res. 42. D1140-D1146 [link]
Thera-SAbDab paper: Raybould, M.I.J., Marks, C. et al (2019). Nucleic Acids Res. gkz827 [link]